AIP
IMVT icon

Ameritas Investment Partners’s Immunovant IMVT Stock Holding History

Ameritas Investment Partners’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
7,744
+1,073
+16% +$32.7K 0.01% 1144
2026
Q1 		$166K Buy
6,671
+963
+17% +$24.9K 0.01% 1385
2025
Q4 		$145K Hold
5,708
– – ﹤0.01% 1470
2025
Q3 		$92K Sell
5,708
-1,268
-18% -$20.5K ﹤0.01% 1741
2025
Q2 		$112K Buy
6,976
+904
+15% +$13.7K ﹤0.01% 1679
2025
Q1 		$104K Hold
6,072
– – ﹤0.01% 1676
2024
Q4 		$150K Buy
6,072
+487
+9% +$13.8K ﹤0.01% 1503
2024
Q3 		$159K Hold
5,585
– – 0.01% 1480
2024
Q2 		$147K Hold
5,585
– – 0.01% 1469
2024
Q1 		$180K Hold
5,585
– – 0.01% 1354
2023
Q4 		$235K Buy
5,585
+224
+4% +$8.24K 0.01% 1161
2023
Q3 		$206K Buy
5,361
+905
+20% +$20.5K 0.01% 1153
2023
Q2 		$84.5K Buy
4,456
+1,315
+42% +$24.5K ﹤0.01% 1711
2023
Q1 		$48.7K Hold
3,141
– – ﹤0.01% 1998
2022
Q4 		$55.9K Hold
3,141
– – ﹤0.01% 1987
2022
Q3 		$17K Hold
3,141
– – ﹤0.01% 2597
2022
Q2 		$12K Hold
3,141
– – ﹤0.01% 2782
2022
Q1 		$17K Hold
3,141
– – ﹤0.01% 2622
2021
Q4 		$27K Hold
3,141
– – ﹤0.01% 2497
2021
Q3 		$27K Hold
3,141
– – ﹤0.01% 2531
2021
Q2 		$33K Hold
3,141
– – ﹤0.01% 2448
2021
Q1 		$50K Hold
3,141
– – ﹤0.01% 2084
2020
Q4 		$145K Buy
3,141
+166
+6% +$7.67K 0.01% 1332
2020
Q3 		$105K Buy
2,975
+1,287
+76% +$38.7K ﹤0.01% 1393
2020
Q2 		$41K Buy
+1,688
New +$36.2K ﹤0.01% 1949

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameritas Investment Partners's IMVT Position: Q2 2026 in Review

Ameritas Investment Partners increased its Immunovant (IMVT) stake by 16% in Q2 2026, buying an estimated $32.7K and bringing the position to 7,744 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #1144.

Ameritas Investment Partners first reported a position in IMVT in Q2 2020 and has held it in 25 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Ameritas Investment Partners held 7,744 shares of Immunovant worth $298K as of Q2 2026.
  • Ameritas Investment Partners bought 1,073 Immunovant shares in Q2 2026, an estimated $32.7K.
  • Immunovant made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1144 holding.
  • Ameritas Investment Partners first reported a position in Immunovant in Q2 2020 and has held it in 25 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.